331 related articles for article (PubMed ID: 34539662)
1. Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency.
Politiek FA; Waterham HR
Front Immunol; 2021; 12():724991. PubMed ID: 34539662
[TBL] [Abstract][Full Text] [Related]
2. Identification of FDA-approved drugs that increase mevalonate kinase in hyper IgD syndrome.
Politiek FA; Turkenburg M; Koster J; Ofman R; Waterham HR
J Inherit Metab Dis; 2024 Mar; 47(2):302-316. PubMed ID: 38131282
[TBL] [Abstract][Full Text] [Related]
3. Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency.
Munoz MA; Jurczyluk J; Simon A; Hissaria P; Arts RJW; Coman D; Boros C; Mehr S; Rogers MJ
Front Immunol; 2019; 10():1900. PubMed ID: 31474985
[TBL] [Abstract][Full Text] [Related]
4. Molecular and cellular consequences of mevalonate kinase deficiency.
Politiek FA; Turkenburg M; Henneman L; Ofman R; Waterham HR
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167177. PubMed ID: 38636615
[TBL] [Abstract][Full Text] [Related]
5. Mevalonate kinase-deficient THP-1 cells show a disease-characteristic pro-inflammatory phenotype.
Politiek FA; Turkenburg M; Ofman R; Waterham HR
Front Immunol; 2024; 15():1379220. PubMed ID: 38550596
[TBL] [Abstract][Full Text] [Related]
6. A role for geranylgeranylation in interleukin-1beta secretion.
Mandey SH; Kuijk LM; Frenkel J; Waterham HR
Arthritis Rheum; 2006 Nov; 54(11):3690-5. PubMed ID: 17075828
[TBL] [Abstract][Full Text] [Related]
7. Respiratory deficiency in yeast mevalonate kinase deficient may explain MKD-associate metabolic disorder in humans.
Santos MMS; Elsztein C; De Souza RB; Paiva SSL; Silva JA; Crovella S; De Morais MA
Curr Genet; 2018 Aug; 64(4):871-881. PubMed ID: 29374778
[TBL] [Abstract][Full Text] [Related]
8. Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency.
Henneman L; Schneiders MS; Turkenburg M; Waterham HR
J Inherit Metab Dis; 2010 Oct; 33(5):625-32. PubMed ID: 20814828
[TBL] [Abstract][Full Text] [Related]
9. Lack of Prenylated Proteins, Autophagy Impairment and Apoptosis in SH-SY5Y Neuronal Cell Model of Mevalonate Kinase Deficiency.
Tricarico PM; Romeo A; Gratton R; Crovella S; Celsi F
Cell Physiol Biochem; 2017; 41(4):1649-1660. PubMed ID: 28359055
[TBL] [Abstract][Full Text] [Related]
10. Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases.
Jurczyluk J; Munoz MA; Skinner OP; Chai RC; Ali N; Palendira U; Quinn JM; Preston A; Tangye SG; Brown AJ; Argent E; Ziegler JB; Mehr S; Rogers MJ
Immunol Cell Biol; 2016 Nov; 94(10):994-999. PubMed ID: 27377765
[TBL] [Abstract][Full Text] [Related]
11. Increased core body temperature exacerbates defective protein prenylation in mouse models of mevalonate kinase deficiency.
Munoz MA; Skinner OP; Masle-Farquhar E; Jurczyluk J; Xiao Y; Fletcher EK; Kristianto E; Hodson MP; O'Donoghue SI; Kaur S; Brink R; Zahra DG; Deenick EK; Perry KA; Robertson AA; Mehr S; Hissaria P; Mulders-Manders CM; Simon A; Rogers MJ
J Clin Invest; 2022 Oct; 132(19):. PubMed ID: 36189795
[TBL] [Abstract][Full Text] [Related]
12. Temperature and drug treatments in mevalonate kinase deficiency: an ex vivo study.
Tricarico PM; Kleiner G; Piscianz E; Zanin V; Monasta L; Crovella S; Marcuzzi A
Biomed Res Int; 2013; 2013():715465. PubMed ID: 24073415
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of mevalonate pathway induces upregulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency.
Pontillo A; Paoluzzi E; Crovella S
Eur J Hum Genet; 2010 Jul; 18(7):844-7. PubMed ID: 20179743
[TBL] [Abstract][Full Text] [Related]
14. Repositioning of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice.
Marcuzzi A; Loganes C; Celeghini C; Kleiner G
Curr Med Chem; 2018; 25(24):2783-2796. PubMed ID: 28901277
[TBL] [Abstract][Full Text] [Related]
15. Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches.
De Leo L; Marcuzzi A; Decorti G; Tommasini A; Crovella S; Pontillo A
Pharmacol Res; 2010 Jun; 61(6):506-10. PubMed ID: 20206266
[TBL] [Abstract][Full Text] [Related]
16. Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation.
Normand S; Massonnet B; Delwail A; Favot L; Cuisset L; Grateau G; Morel F; Silvain C; Lecron JC
Eur Cytokine Netw; 2009 Sep; 20(3):101-7. PubMed ID: 19825518
[TBL] [Abstract][Full Text] [Related]
17. Unprenylated RhoA contributes to IL-1β hypersecretion in mevalonate kinase deficiency model through stimulation of Rac1 activity.
van der Burgh R; Pervolaraki K; Turkenburg M; Waterham HR; Frenkel J; Boes M
J Biol Chem; 2014 Oct; 289(40):27757-65. PubMed ID: 25107911
[TBL] [Abstract][Full Text] [Related]
18. A possibly new autoinflammatory disease due to compound heterozygous phosphomevalonate kinase gene mutation.
Yıldız Ç; Gezgin Yıldırım D; Inci A; Tümer L; Cengiz Ergin FB; Sunar Yayla ENS; Esmeray Şenol P; Karaçayır N; Eğritaş Gürkan Ö; Okur I; Ezgü FS; Bakkaloğlu SA
Joint Bone Spine; 2023 Jan; 90(1):105490. PubMed ID: 36410683
[TBL] [Abstract][Full Text] [Related]
19. Current advances in the understanding and treatment of mevalonate kinase deficiency.
Esposito S; Ascolese B; Senatore L; Bosis S; Verrecchia E; Cantarini L; Rigante D
Int J Immunopathol Pharmacol; 2014; 27(4):491-8. PubMed ID: 25572728
[TBL] [Abstract][Full Text] [Related]
20. Mevalonate kinase deficiency: current perspectives.
Favier LA; Schulert GS
Appl Clin Genet; 2016; 9():101-10. PubMed ID: 27499643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
